ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡
By K. Dickstein, A. Cohen‐Solal, Gerasimos Filippatos, J. McMurray, P. Ponikowski, P. Poole-Wilson, Anna Strömberg, D. Veldhuisen, D. Atar, A. Hoes and 37 more. European Journal of Heart Failure, 2008
2,419 citations recorded by the source corpus.
Authors/Task Force Members: Kenneth Dickstein (Chairperson) (Norway)*, Alain Cohen-Solal (France), Gerasimos Filippatos (Greece), John J.V. McMurray (UK), Piotr Ponikowski (Poland), Philip Alexander Poole-Wilson (UK), Anna Strömberg (Sweden), Dirk J. van Veldhuisen (The Netherlands), Dan Atar (Norway), Arno W. Hoes (The Netherlands), Andre Keren (Israel), Alexandre Mebazaa (France), Markku Nieminen (Finland), Silvia Giuliana Priori (Italy), Karl Swedberg (Sweden)
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/725bc12489d2d02a5f5065b33112059027407340
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Véronique A. Cornelissen
- Jeroen J. Bax
- Helmut Baumgartner
- Paulus Kirchhof
- Gerasimos Filippatos
- Frank Flachskampf
- Volkmar Falk
- M. Flemmer
Citations in the corpus
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2012, neutral): “This diagnosis requires management according to guidelines for the treatment of chronic heart failure.(284) Selected patients with symptomatic, chronic heart failure and a reduced ejection fraction or electrical dyssynchrony, as evidenced by QRS prolongation, may satisfy criteria for implantation of”
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, neutral): “Dietary sodium restriction is commonly recommended to patients with HF and is endorsed by many guidelines.(18,376,377) The data on which this recommendation is drawn upon, however, are modest, and variances in protocols, fluid intake, measurement of sodium intake and compliance, and other clinical a”
- Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. (2020, positive): “Up-titration of CHF medication was derived from the 2016 ESC guidelines.(2) Concerning exercise training, emphasis was put on the systematic adoption of the FITT (frequency, intensity, time – duration – and type of exercise) prescription model.”
- Ferric carboxymaltose in patients with heart failure and iron deficiency. (2009, neutral): “Vescovo, Unità Locale Socio Sanitaria 6 Ospedale San Bortolo, Vicenza; Norway (2): K.”
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, neutral): “Dietary sodium restriction is commonly recommended to patients with HF and is endorsed by many guidelines (18,376,377).”
- Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, neutral): “Several mechanisms operating in heart failure can predispose to AF by creating either a substrate or a trigger for this arrhythmia.(44,168) AF constitutes a strong and independent risk factor for the development of heart failure, and both conditions frequently co-exist,(44)”
- Iron deficiency: an ominous sign in patients with systolic chronic heart failure. (2010, positive): “%) and found using bone marrow biopsies that 73% presented with ID. Patients with CHF are prone to become iron deficient as a consequence of a depletion of iron stores (absolute ID) or more frequently as a result of impaired iron metabolism in the course of inflammatory processes characterizing CHF ”